ATE87331T1 - Hefe-promotor. - Google Patents

Hefe-promotor.

Info

Publication number
ATE87331T1
ATE87331T1 AT87307668T AT87307668T ATE87331T1 AT E87331 T1 ATE87331 T1 AT E87331T1 AT 87307668 T AT87307668 T AT 87307668T AT 87307668 T AT87307668 T AT 87307668T AT E87331 T1 ATE87331 T1 AT E87331T1
Authority
AT
Austria
Prior art keywords
activation sequence
upstream activation
pgk
gal10
hybrid
Prior art date
Application number
AT87307668T
Other languages
English (en)
Inventor
Susan Mary Kingsman
Mark Julian Wilson
Diane Joan Cousens
Edward Hinchliffe
Original Assignee
Delta Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delta Biotechnology Ltd filed Critical Delta Biotechnology Ltd
Application granted granted Critical
Publication of ATE87331T1 publication Critical patent/ATE87331T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT87307668T 1986-08-29 1987-08-28 Hefe-promotor. ATE87331T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868620926A GB8620926D0 (en) 1986-08-29 1986-08-29 Yeast promoter
EP87307668A EP0258067B1 (de) 1986-08-29 1987-08-28 Hefe-Promotor

Publications (1)

Publication Number Publication Date
ATE87331T1 true ATE87331T1 (de) 1993-04-15

Family

ID=10603398

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87307668T ATE87331T1 (de) 1986-08-29 1987-08-28 Hefe-promotor.

Country Status (13)

Country Link
US (1) US5739007A (de)
EP (1) EP0258067B1 (de)
JP (1) JP2641457B2 (de)
AT (1) ATE87331T1 (de)
AU (1) AU604257B2 (de)
CA (1) CA1291428C (de)
DE (1) DE3784986T2 (de)
DK (1) DK173186B1 (de)
ES (1) ES2054682T3 (de)
FI (1) FI96620C (de)
GB (2) GB8620926D0 (de)
IE (1) IE59986B1 (de)
ZA (1) ZA876447B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003008A1 (en) * 1985-11-13 1987-05-21 International Genetic Engineering, Inc. Shortened phosphoglycerate kinase promoter
GB8725529D0 (en) * 1987-10-30 1987-12-02 Delta Biotechnology Ltd Polypeptides
IL89992A0 (en) * 1988-04-25 1989-12-15 Phillips Petroleum Co Expression of human serum albumin in methylotrophic yeasts
FR2634495B1 (fr) * 1988-07-01 1990-10-26 Chambon Pierre Procede de preparation d'une proteine par des levures utilisant un systeme inductible, vecteurs et souches transformees correspondantes
FR2649991B2 (fr) * 1988-08-05 1994-03-04 Rhone Poulenc Sante Utilisation de derives stables du plasmide pkd1 pour l'expression et la secretion de proteines heterologues dans les levures du genre kluyveromyces
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
GB9526733D0 (en) 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
GB9712370D0 (en) 1997-06-14 1997-08-13 Aepact Ltd Therapeutic systems
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
EP1803730A1 (de) 2000-04-12 2007-07-04 Human Genome Sciences, Inc. Albuminfusionsproteine
US20050054051A1 (en) * 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
US7507413B2 (en) * 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
CA2484556A1 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin fusion proteins
EP1997829A1 (de) 2001-12-21 2008-12-03 Human Genome Sciences, Inc. Albumin Fusionsproteine
JP2005538932A (ja) 2002-02-07 2005-12-22 アベンティス、ベーリング、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング アルブミン融合クニッツドメインペプチド
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
GB0329681D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Gene expression technique
GB0329722D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
US8420087B2 (en) 2004-01-05 2013-04-16 Antisoma Research Limited Interleukin-12 targeted to oncofoetal fibronectin
AU2005317828A1 (en) 2004-12-23 2006-06-29 Novozymes Delta Limited Gene expression technique
EP1893628B1 (de) * 2005-06-14 2010-09-22 Merck Sharp & Dohme Corp. Kontrollregion eines synthetischen gens
KR101193722B1 (ko) 2006-07-24 2013-01-11 바이오렉시스 파마슈티칼 코포레이션 엑센딘 융합 단백질
EP2054437A2 (de) 2006-08-07 2009-05-06 Teva Biopharmaceuticals USA, Inc. Albumin-insulin-fusionsproteine
WO2008098720A1 (en) 2007-02-12 2008-08-21 Csl Behring Gmbh Therapeutic application of kazal-type serine protease inhibitors
CN101835801B (zh) 2007-08-08 2014-09-10 诺维信生物制药丹麦公司 转铁蛋白变体和偶联物
JP2011517410A (ja) * 2008-04-08 2011-06-09 アミリス バイオテクノロジーズ， インコーポレイテッド 異種配列の発現
WO2010089385A1 (en) 2009-02-06 2010-08-12 Novozymes Biopharma Dk A/S Purification process
JP5936112B2 (ja) 2009-02-11 2016-06-15 アルブミディクス アクティーゼルスカブ アルブミン変異体及び複合体
EP2371857A1 (de) 2010-04-01 2011-10-05 CSL Behring GmbH Faktor-XII-Inhibitoren zur Behandlung von interstitieller Pneumonie
CN103732628B (zh) 2011-03-03 2017-06-23 酵活有限公司 多价杂多聚体骨架设计和构建体
CA2878640C (en) 2012-07-13 2023-10-24 Zymeworks Inc. Multivalent heteromultimer scaffold design and constructs
CA2910945A1 (en) 2013-05-08 2014-11-13 Zymeworks Inc. Bispecific her2 and her3 antigen binding constructs
CA2874083C (en) 2014-12-05 2024-01-02 Universite Laval Tdp-43-binding polypeptides useful for the treatment of neurodegenerative diseases
MA43571A (fr) 2015-12-23 2018-11-14 Biogen Ma Inc Protéines contenant un domaine riche en cystéine 2 dkk2 et leurs utilisations
CN113508135A (zh) 2018-10-29 2021-10-15 比奥根Ma公司 增强血脑屏障转运的人源化和稳定化的fc5变体
CN113462686B (zh) * 2020-03-30 2023-06-02 中国科学院深圳先进技术研究院 制备具有梯度活性的半乳糖诱导合成启动子的方法、及其制备的启动子、应用
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
MX2023007767A (es) 2020-12-28 2023-07-07 Davol Inc Materiales hemostaticos secos en polvo reactivos que comprenden una proteina y un agente de entrelazado a base de polietilenglicol modificado multifuncional.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK368882A (da) * 1981-08-25 1983-02-26 Alan John Kingsman Expessions vektorer
US4803164A (en) * 1981-08-31 1989-02-07 Genentech, Inc. Preparation of hepatitis b surface antigen in yeast
US4876197A (en) * 1983-02-22 1989-10-24 Chiron Corporation Eukaryotic regulatable transcription
GB8314961D0 (en) * 1983-05-31 1983-07-06 Kingsman A J Dna sequence
DE3587759T2 (de) * 1984-05-11 1994-07-07 Chiron Corp., Emeryville, Calif. Erhöhte Hefetranskription unter Verwendung einer Hybridkonstruktion der Promotorregion.
EP0225887B1 (de) * 1985-04-08 1994-06-08 Amgen Inc. Verfahren und hybridpromotor zur steuerung der exogenen gentranskription
GB8510219D0 (en) * 1985-04-22 1985-05-30 Bass Plc Isolation of fermentation products
GB8521496D0 (en) * 1985-08-29 1985-10-02 Ciba Geigy Ag Repressible yeast promoters
MY101203A (en) * 1985-12-12 1991-08-17 Ucp Gen Pharma Ag Production of thrombin iinhibitors.

Also Published As

Publication number Publication date
US5739007A (en) 1998-04-14
GB2196635A (en) 1988-05-05
IE872308L (en) 1988-02-29
GB8620926D0 (en) 1986-10-08
FI873729A0 (fi) 1987-08-27
EP0258067A2 (de) 1988-03-02
GB8720396D0 (en) 1987-10-07
CA1291428C (en) 1991-10-29
JP2641457B2 (ja) 1997-08-13
EP0258067B1 (de) 1993-03-24
FI873729L (fi) 1988-03-01
FI96620B (fi) 1996-04-15
IE59986B1 (en) 1994-05-04
DK447287A (da) 1988-05-20
DE3784986D1 (en) 1993-04-29
GB2196635B (en) 1990-12-05
ZA876447B (en) 1988-05-25
DE3784986T2 (de) 1993-07-01
JPS63112988A (ja) 1988-05-18
DK173186B1 (da) 2000-03-06
FI96620C (fi) 1996-07-25
ES2054682T3 (es) 1994-08-16
AU7765787A (en) 1988-05-19
DK447287D0 (da) 1987-08-27
EP0258067A3 (en) 1989-05-10
AU604257B2 (en) 1990-12-13

Similar Documents

Publication Publication Date Title
ATE87331T1 (de) Hefe-promotor.
ES2001805A6 (es) Procedimiento para la preparacion de una crema terapeutica con elevada estabilidad y buena eficacia.
IE831226L (en) Method for preparing 26,26,26,27,27,27-hexafluoro-1ó,25-¹dihydrocholestrol
IE841494L (en) Androsta-1,4-diene-3,17-diones
EP0330234A3 (de) Grundiermittelzusammensetzung
AU4291285A (en) Compositions of polycycloalkenyl-terminated, unsaturated polyesters or polyesteramides and vinyl-reactive plasticizers therefor
ES2093635T3 (es) Promotor de levadura.
EP0255485A3 (de) Transdermale Mittel
CA2056364A1 (en) Compositions and methods of effecting contraception
IE42112L (en) 2-BROMO-6ß-FLUOROPREGNA-1,4-DIENE-3,20-DIONES
ES357936A1 (es) Procedimiento de preparacion de los 3-oxo gonatrienos.
JPS6490120A (en) Cataplasm providing cool feeling
GB1164705A (en) Preparation of Delta<7>-Dehydro Steroids
JPS5225328A (en) Body construction of automobiles
ES8507155A3 (es) Metodo para la obtencion de esteroides de la serie de prednisolona
Mitchell Locus of control, personality, and preference for therapy of alcoholics: an experimental study
KIKUZAWA Translocations of the boundary diameter points in an artificial Saghalien fir stand
IE880782L (en) Preventing over-speeding of an i.c. engine
IE880708L (en) Preventing over-speeding of an i.c. engine
IE880709L (en) Preventing over-speeding of an i.c. engine
KR850008339A (ko) 이소퀴놀린 유도체, 그의 제법 및 그의 응용
ES8202326A1 (es) Procedimiento para la preparacion de esteres de acidos aril-propionicos
ZA872400B (en) Cementiferous compositions and additives for use in such compositions
KR940014433A (ko) 감마(γ)-엘(L)-글루타밀-엘(L)-시스테인 에틸 에스테르의 제조방법

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time